BeStock  
Stocks › Biotechnology › HRMY

Harmony Biosciences HRMY

US equityMarket cap rank #2704Biotechnology
$32.59 −$0.39 (-1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.59 0.00%
Open$32.68
Prev close$32.98
Day range$32.51 – $33.43
Volume582.6K
Market cap$1.91B
P/E (TTM)10.8
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership114.3%+6.25 pts vs. prior quarter
Institutions holding421+29 vs. prior quarter
Insider trades (recent)24 buys / 23 sellsNet buying
Short interest11.44% of floatDays to cover 5.6 · as of 30 Oct 2026
Short-sale volume share18.1%5-day average of daily volume

Short-sale volume as % of daily volume

13%19%25%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$6.08M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$3.5MSuper−$2.6MBig+$1.2MMid+$4.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.8% of shares outstanding.

Largest holders

  • BlackRock12.54%
  • Marshman Fund Trust II10.30%
  • FMR5.57%
  • American Century Investment Management5.30%
  • Vanguard Portfolio Management, LLC5.06%
  • Dimensional Fund Advisors4.51%
  • Vanguard Capital Management, LLC3.76%
  • LSV Asset Management3.75%

By investor type

  • Mutual Fund75.04%
  • Hedge Fund13.93%
  • Private Company13.49%
  • VC/PE Fund5.90%
  • Public Company3.18%
  • Government Pension Fund1.45%
  • Family Office/Trust0.80%
  • Sovereign Wealth Fund0.26%

Reported short interest has risen from 7.10% to 11.44% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Allspring Global Investments, LLC Mutual Fund 2026/Q3 +951,273 1.9%
Emerald Advisers, LLC Mutual Fund 2026/Q3 +578,630 1.0%
American Century Investment Management Mutual Fund 2026/Q3 +573,906 5.3%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +393,166 0.7%
State Street Global Advisors Mutual Fund 2026/Q3 +271,274 3.6%
BlackRock Mutual Fund 2026/Q3 +259,923 12.5%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +256,387 4.5%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +202,200 2.4%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +199,521 0.4%
Handelsbanken Asset Management Mutual Fund 2026/Q3 +180,626 0.4%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +171,370 1.1%
Penn Capital Management Company, LLC Mutual Fund 2026/Q3 +149,366 0.3%
LSV Asset Management Mutual Fund 2026/Q3 +143,780 3.8%
Valor Management LLC VC/PE Fund 2026/Q3 +700,883 1.4%
American Century Investment Management Mutual Fund 2026/Q3 +434,333 4.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
17 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Intent to Sell (Form 144) -35,852 $42.74 –
17 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Derivative Exercise and Sale -38,452 $43.05 13,115
16 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Intent to Sell (Form 144) -800 $42.21 –
15 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Intent to Sell (Form 144) -1,800 $42.17 –
7 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Derivative Exercise and Sale -22,954 $43.10 13,115
7 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Automatic Disposition -11,000 $42.79 13,115
3 Sep 2026 Kumar Budur Executive VP and Chief Medical & Scientific Officer Intent to Sell (Form 144) -5,500 $41.86 –
6 Aug 2026 Valor Management LLC Intent to Sell (Form 144) -700,883 $37.90 –
15 Jul 2026 Stephen Mollichella Senior VP, Controller & Interim Principal Financial Officer Initial Statement of Beneficial +0 – 48,472
1 Jul 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -25,000 $36.96 –
29 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -50,000 $36.08 –
25 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -45,594 $35.24 –
23 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -4,406 $35.02 –
8 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -27,960 $33.74 –
4 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -2,101 $33.08 –
3 Jun 2026 Sandip Kapadia Former Chief Financial Officer Intent to Sell (Form 144) -7,064 $33.02 –
13 May 2026 R. Graf Independent Director Other Derivative Acquisition +21,872 $30.76 21,872
13 May 2026 Gary Sender Independent Director Other Derivative Acquisition +21,872 $30.76 21,872
13 May 2026 Linda Szyper Independent Director Other Derivative Acquisition +21,872 $30.76 21,872
13 May 2026 Geno Germano Independent Director Other Derivative Acquisition +21,231 $30.76 21,231

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,664,944 11.4% 5.6
15 Oct 2026 5,413,347 9.3% 6.2
30 Sep 2026 5,532,301 9.5% 5.0
15 Sep 2026 4,628,716 7.9% 4.3
31 Aug 2026 5,164,996 8.9% 9.1
14 Aug 2026 4,136,259 7.1% 4.8

Discussion

No comments yet — be the first to weigh in on HRMY.

Sign in to join the discussion.

Scroll to Top